MedTrace Logo

Evaluation of Binocular Visual Acuity and Refractive Stability in the Alcon Clareon Intraocular Lens

NCT04936256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2024-08-07

Study results available
· View outcomes & findings →

Summary

The objective is to evaluate refractive stability (spherical equivalent change ≤ 0.50D from 1-month to 3-months).

Conditions

  • Cataract

Interventions

DEVICE

Clareon

Clareon monofocal intraocular lens (IOL)

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Gainesville Eye Associates

    lead OTHER

Principal Investigators

  • Clayton Blehm, MD · Gainesville Eye Associates

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-02
Primary Completion
2022-07-28
Completion
2022-07-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04936256 on ClinicalTrials.gov